Modern triple therapy regimens, including SGLT2 inhibitors and GLP-1 receptor agonists, are more efficacious but significantly more expensive than older regimens.

“now it's interesting when you talk about today's triple therapy which is way more efficacious two of those three drugs are very expensive yes the SG tatto Inhibitors are very expensive in the modern day gen 3 Gen 4 and soon we'll have a Gen 5 go1 they're very pricey they're very ,000 a month for the yeah”